8-KThe WireRed Alert
Executive Change · Bylaw Amendment
Filed Jun 4, 2026 · 26d ago · Accession 0001193125-26-257593
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- CRISPR Therapeutics AG
- Ticker
- CRSP
- CIK
- 1674416
- Form type
- 8-K
- Filing date
- Jun 4, 2026
- Report date
- Jun 4, 2026
- Document
- crsp-20260604.htm
- Size
- 1.5 MB